- Home
- STEM vs FLNA Comparison
STEM vs FLNA Comparison
Compare STEM & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STEM | FLNA |
|---|---|---|
| Founded | 2009 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.6M | 61.8M |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | STEM | FLNA |
|---|---|---|
| Price | $5.46 | $0.93 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.33 | N/A |
| AVG Volume (30 Days) | 127.2K | ★ 297.0K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $156,266,000.00 | $41,119,000.00 |
| Revenue This Year | $2.77 | N/A |
| Revenue Next Year | $14.65 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.08 | N/A |
| 52 Week Low | $4.92 | $0.85 |
| 52 Week High | $32.23 | $2.03 |
Technical Indicators
Market Signals| Indicator | STEM | FLNA |
|---|---|---|
| Relative Strength Index (RSI) | 40.32 | 42.88 |
| Support Level | $5.13 | $0.86 |
| Resistance Level | $6.15 | $1.05 |
| Average True Range (ATR) | 0.47 | 0.06 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 5.92 | 36.84 |
Price Performance
Historical ComparisonAbout STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.
About FLNA Filana Therapeutics Inc. Common Stock
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.